Incorporating the Patient Voice: How Patient Insights Drive Trial Design and Outcome Measures in Schizophrenia Research
Schizophrenia is a complex and challenging condition that significantly impacts patients’ lives. Traditional clinical trial designs often fail to capture the full spectrum of patient experiences and outcomes. By incorporating patient insights, we can develop more patient-centric trials that improve recruitment and retention and ensure that the outcomes measured are meaningful to those living with the condition.
Join us for an insightful webinar that delves into the critical role of patient insights in optimizing clinical trial design and outcome measures for schizophrenia studies. Moderated by Dr. Mohit Verma, global therapeutic area head of psychiatry at Parexel, this session will feature leading experts from Parexel’s feasibility and clinical operations teams.
Key Topics:
- Changing regulatory landscape: Insights into recent interactions with regulatory agencies and implications for advancing novel therapies.
- Patient insights in trial design: Best practices for engaging patients and caregivers to inform protocol design, eligibility criteria, and recruitment/retention strategies.
- Innovative outcome measures: Development and validation of patient-reported outcomes and other endpoints, including new digital tools for assessing cognitive impairment.
- Future directions: Impact of global events on trial recruitment, precision medicine approaches, and strategies for reaching targeted patient populations.
Speakers:
Moderator: Mohit Verma, M.D., Global Therapeutic Area Head, Psychiatry, Parexel
Panelists:
- Jaime Roberts, Associate Director, Feasibility Strategy, Parexel
- Katja Rudell, Senior Director, Clinical Outcomes Assessment, Parexel
Who Should Attend: This webinar is essential for sponsors, researchers, regulators, and drug developers working on innovative therapies for schizophrenia. Gain expert perspectives on navigating the complex landscape of schizophrenia clinical trials and drug development.
Related Insights
Blog
Improving and accelerating clinical research in dementia by integrating the patient’s voice throughout the development journey
Jan 24, 2024
Blog
Building a program for patient-guided clinical research for Alzheimer’s disease
Jan 24, 2024
Report
New Medicines, Novel Insights: Accelerating the new frontiers in neuroscience
Oct 29, 2024
Blog
Patient Advocacy Groups: A vital partner for sponsors that understand how to engage with patients
May 3, 2022
Blog
New CNS Franchise Leader brings experience from pharma and as a clinician and researcher
Nov 14, 2022
Article
Relyvrio Approval: Lessons Learned
Oct 31, 2022
Blog
Inclusion for all: Expanding trial accessibility for transgender and nonbinary patients
Sep 23, 2022
Blog
Including patients in DCT design
Sep 13, 2022
Blog
Taking a Proactive Approach to Post-Launch Patient Accessibility in Strategic Planning
Aug 4, 2022
Video
A Life in a Day
Jul 28, 2022
Video
Parexel Site Alliances
Jul 13, 2022
Video
Nurse Advisory Panel
Jul 13, 2022
Related Insights
Blog
Improving and accelerating clinical research in dementia by integrating the patient’s voice throughout the development journey
Jan 24, 2024
Blog
Building a program for patient-guided clinical research for Alzheimer’s disease
Jan 24, 2024
Report
New Medicines, Novel Insights: Accelerating the new frontiers in neuroscience
Oct 29, 2024
Blog
Patient Advocacy Groups: A vital partner for sponsors that understand how to engage with patients
May 3, 2022
Blog
New CNS Franchise Leader brings experience from pharma and as a clinician and researcher
Nov 14, 2022
Article
Relyvrio Approval: Lessons Learned
Oct 31, 2022
Blog
Inclusion for all: Expanding trial accessibility for transgender and nonbinary patients
Sep 23, 2022
Blog
Including patients in DCT design
Sep 13, 2022
Blog
Taking a Proactive Approach to Post-Launch Patient Accessibility in Strategic Planning
Aug 4, 2022
Video
A Life in a Day
Jul 28, 2022
Video
Parexel Site Alliances
Jul 13, 2022
Video
Nurse Advisory Panel
Jul 13, 2022